Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study)

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Increased risk of Staphylococcus aureus bacteremia in hemodialysis-A nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Treatment of a soft tissue calcification in a patient receiving peritoneal dialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Home hemodialysis: infrastructure, water, and machines in the home

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Pulse contour-derived cardiac output in hemodialysis patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Non-eosinophilic severe exacerbations of COPD: what about antibiotics? - Authors' reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Regional and socioeconomic variation in survival of melanoma patients in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Thyroid peroxidase antibodies and prospective live birth rate: A cohort study of women with recurrent pregnancy loss

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Low-grade chronic inflammation is common in hemodialysis (HD) patients. Previous studies suggest an anti-inflammatory effect of angiotensin II receptor blocker (ARB) treatment. The aim of this study was to compare the effect of ARB vs. placebo on plasma concentrations of inflammatory markers in HD patients.

METHODS: Adult HD patients were randomized for double-blind treatment with the ARB irbesartan 150-300 mg/day or placebo. At baseline, 1 week, 3, 6, 9, and 12 months plasma high sensitivity C-reactive protein (hsCRP), interleukin (IL)-1β, IL-6, IL-8, IL-18, and transforming growth factor-β (TGF-β) were measured using Luminex and enzyme-linked immunosorbent assay (ELISA) technology.

FINDINGS: Eighty-two patients were randomized (placebo/ARB: 41/41). The groups did not differ in initial levels of any of the inflammatory markers (placebo/ARB median(range)): hsCRP 3.3(0.2-23.4)/2.7(0.2-29.6) μg/mL; IL-1β 1.1(0.0-45.9)/1.1(0.0-7.2) pg/mL; IL-6 10(1-90)/12(1-84) pg/mL; IL-8 31(9-134)/34(5-192) pg/mL; IL-18 364(188-1343)/377(213-832) pg/mL; TGF-β 3.2(0.8-13.9)/3.6(1.3-3.8) ng/mL. Overall, there was no significant difference in hsCRP, IL-6, IL-8, and TGF-β between placebo and ARB-treated patients during the study period, and hsCRP, IL-6, IL-8, and TGF-β were relatively stable during the study period (P ≥ 0.18 in all tests for parallel curves, equal levels, and constant levels). The IL-1β level was slightly different in the two groups over time, but not significantly (P = 0.09 in test for parallel curves) and it was also relatively stable during the study period (P ≥ 0.49 in tests for equal levels and constant level). IL-18 was the only inflammatory marker which was not constant during the study period (P = 0.001 in test for constant level), but there was no significant difference between placebo and ARB-treated (P ≥ 0.51 in tests for parallel curves and equal levels).

DISCUSSION: Inflammatory biomarkers were neither acutely, nor in the long-term significantly affected by the ARB irbesartan. Our findings suggest that ARB treatment in HD patients does not offer protective anti-inflammatory effects.

Original languageEnglish
JournalHemodialysis international. International Symposium on Home Hemodialysis
Volume21
Issue number1
Pages (from-to)47-62
Number of pages16
ISSN1492-7535
DOIs
Publication statusPublished - Jan 2017

    Research areas

  • Angiotensin II Type 1 Receptor Blockers, Biomarkers, Biphenyl Compounds, Double-Blind Method, Female, Humans, Male, Middle Aged, Renal Dialysis, Tetrazoles, Journal Article, Randomized Controlled Trial

ID: 52388377